A Phase 3, Randomized Double-Blind, Placebo-Controlled Multicenter Study to Evaluate Efficacy and Safety of Repeated Administration of NurOwn® (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) in Participants With ALS

Investigator(s):
Namita Goyal, M.D.;
Organization: 
UCI
NCT Number: 
Disease Name: 
Amyotrophic Lateral Sclerosis (ALS)
Disease Category: 
Trial Phases: 
Phase 3
Trial Status: 
Recruiting
Trial Contact: 

Active trials at UCI: http://clinic.stemcell.uci.edu/search-clinical-trials.asp

Contact for all open studies at UCI:
(949) 824-3990
stemcell@uci.edu